로딩 중…
지수 로딩 중…
CTCBIO Inc.
060590· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩3,035-3.65%
2026-06-19
Price Chart
CTCBIO Inc.-54.15%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 73.39B KRW |
| Revenue | 124.11B KRW |
| Net Income | 1.10B KRW |
| Total Assets | 146.65B KRW |
| Net Assets | 76.22B KRW |
| Employees | 257 |
| Value | |
| P/E | 66.67x |
| P/B | 0.96x |
| PEG | 0.15x |
| P/S | 0.59x |
| EV/EBITDA | 14.23x |
| FCF Yield | 4.90% |
| Profitability | |
| ROE | 1.44% |
| ROA | 0.75% |
| Op. Margin | 5.15% |
| Revenue Growth | 1.00% |
| Earnings Growth | 451.04% |
| Financial Health | |
| Debt Ratio | 192.40% |
| Total Debt | 35.70B KRW |
| FCF | 3.60B KRW |
| Cash | 18.20B KRW |
| Current Ratio | 1.47x |
| Net Debt/EBITDA | 2.74x |
| Performance | |
| 1Y Return | -54.15% |
| 1M Return | -15.93% |
| From 52W High | -60.48% |
| 1Y MDD | -59.26% |
| Trading | |
| Volume | 104,072 shares |
| Foreign Own. | 2.26% |
| Per Share | |
| EPS | 252 KRW |
| BPS | 3,188 KRW |
Company Info
CTC BIO, established in 1995 and headquartered in Hwaseong-si, Gyeonggi-do, listed on KOSDAQ in 2002. The company researches, develops, manufactures, and distributes animal pharmaceuticals, including feed additives, injectables, and vaccines, as well as improved new drugs and generic drugs. CTC BIO possesses 5 domestic production bases, 2 research institutes, and operates local subsidiaries in the USA and Indonesia, expanding its production base by acquiring the Ansan factory from SK Chemicals in 2014. Its technological prowess is recognized through core technologies such as microbial fermentation and drug coating, alongside the development of innovative film-type and complex formulations.